Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
Announced private placement of up to $19.25M with healthcare funds and insidersReceived $3M award recommendation from the..
Announced private placement of up to $19.25M with healthcare funds and insidersReceived $3M award recommendation from the..
Backed by healthcare and data experts, Integral enables faster insights to produce better patient outcomes, increase access to..
ReSPECT-GBM clinical trial of rhenium (^186Re) obisbemeda in recurrent glioblastoma continues to demonstrate safety and overall..